115 related articles for article (PubMed ID: 15225480)
1. [Prevalence of perinuclear antineutrophil cytoplasmic antibodies (pANCA) in inflammatory bowel disease].
López Serrano P; Santander C; Fernández Rodríguez C
Med Clin (Barc); 2004 Jun; 123(3):119. PubMed ID: 15225480
[No Abstract] [Full Text] [Related]
2. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.
Quinton JF; Sendid B; Reumaux D; Duthilleul P; Cortot A; Grandbastien B; Charrier G; Targan SR; Colombel JF; Poulain D
Gut; 1998 Jun; 42(6):788-91. PubMed ID: 9691915
[TBL] [Abstract][Full Text] [Related]
3. The prevalence and diagnostic value of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease in mainland China.
Zhou F; Xia B; Wang F; Shrestha UK; Chen M; Wang H; Shi X; Chen Z; Li J
Clin Chim Acta; 2010 Oct; 411(19-20):1461-5. PubMed ID: 20570669
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease.
Kim BG; Kim YS; Kim JS; Jung HC; Song IS
Dis Colon Rectum; 2002 Aug; 45(8):1062-9. PubMed ID: 12195191
[TBL] [Abstract][Full Text] [Related]
5. [Differential diagnosis of chronic inflammatory bowel diseases. Value of determination of autoantibodies pANCA, ASCA AND PAB (perinuclear antineutrophil cytoplasmic antibody, antibody against Saccharomyces cerevisiae, antibody against pancreas)].
Seibold F; Hufnagl R; Scheurlen M
Fortschr Med; 1999 Feb; 117(6):42-3. PubMed ID: 10095303
[No Abstract] [Full Text] [Related]
6. Evaluation of perinuclear antineutrophilic cytoplasmic antibodies in sera from dogs with inflammatory bowel disease or intestinal lymphoma.
Mancho C; Sainz Á; García-Sancho M; Villaescusa A; Rodríguez-Franco F
Am J Vet Res; 2011 Oct; 72(10):1333-7. PubMed ID: 21962275
[TBL] [Abstract][Full Text] [Related]
7. [Role of perinuclear antibodies against cytoplasm of neutrophilic granulocytes (p-ANCA) in the diagnosis of vasculitis and chronic inflammatory diseases].
Oudkerk Pool M
Ned Tijdschr Geneeskd; 1997 Jan; 141(1):63-4. PubMed ID: 9162858
[No Abstract] [Full Text] [Related]
8. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P
Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
[TBL] [Abstract][Full Text] [Related]
9. Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis.
Hov JR; Boberg KM; Taraldsrud E; Vesterhus M; Boyadzhieva M; Solberg IC; Schrumpf E; Vatn MH; Lie BA; Molberg Ø; Karlsen TH
Liver Int; 2017 Mar; 37(3):458-465. PubMed ID: 27558072
[TBL] [Abstract][Full Text] [Related]
10. Anti-alpha-enolase antibodies in patients with inflammatory Bowel disease.
Vermeulen N; Arijs I; Joossens S; Vermeire S; Clerens S; Van den Bergh K; Michiels G; Arckens L; Schuit F; Van Lommel L; Rutgeerts P; Bossuyt X
Clin Chem; 2008 Mar; 54(3):534-41. PubMed ID: 18218721
[TBL] [Abstract][Full Text] [Related]
11. The significance of pANCA in inflammatory bowel disease.
Radford-Smith GL; Bansal A
J Gastroenterol Hepatol; 1998 Sep; 13(9):863-4. PubMed ID: 9794182
[No Abstract] [Full Text] [Related]
12. [Antineutrophil cytoplasmic antibodies (ANCA) in chronic inflammatory intestinal disease].
García Herola A; Nos Mateu P; Ponce García J
Gastroenterol Hepatol; 2000 Jan; 23(1):16-23. PubMed ID: 10726379
[No Abstract] [Full Text] [Related]
13. Perinuclear antineutrophilic cytoplasmic antibody and response to treatment in diarrheic dogs with food responsive disease or inflammatory bowel disease.
Luckschander N; Allenspach K; Hall J; Seibold F; Gröne A; Doherr MG; Gaschen F
J Vet Intern Med; 2006; 20(2):221-7. PubMed ID: 16594575
[TBL] [Abstract][Full Text] [Related]
14. pANCA positivity predicts lower clinical response to infliximab therapy among patients with IBD.
Nguyen DL; Nguyen ET; Bechtold ML
South Med J; 2015 Mar; 108(3):139-43. PubMed ID: 25772045
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of serological markers in inflammatory bowel disease.
Mokrowiecka A; Daniel P; Słomka M; Majak P; Malecka-Panas E
Hepatogastroenterology; 2009; 56(89):162-6. PubMed ID: 19453050
[TBL] [Abstract][Full Text] [Related]
16. Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies: serologic markers in inflammatory bowel disease.
Hartman C; Eliakim R; Shamir R
Isr Med Assoc J; 2004 Apr; 6(4):221-6. PubMed ID: 15115261
[No Abstract] [Full Text] [Related]
17. Predictive value of serologic markers in a population-based Norwegian cohort with inflammatory bowel disease.
Solberg IC; Lygren I; Cvancarova M; Jahnsen J; Stray N; Sauar J; Schreiber S; Moum B; Vatn MH;
Inflamm Bowel Dis; 2009 Mar; 15(3):406-14. PubMed ID: 19009607
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic tools in inflammatory bowel diseases].
Bouhnik Y
Rev Prat; 2005 May; 55(9):977-83. PubMed ID: 16052968
[TBL] [Abstract][Full Text] [Related]
19. [Anti-neutrophil cytoplasmic antibodies in the diagnosis of ulcerative colitis and Crohn's disease].
Gisbert JP; Luna M; Legido J; Hermida C; Maté J; Pajares JM
Med Clin (Barc); 2004 Feb; 122(4):134-5. PubMed ID: 14967094
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibody in Iranian patients with inflammatory bowel disease.
Bahari A; Aarabi M; Aarabi M; Hedayati M; Jarollahi A; Firouzi F; Aghazadeh R; Zali MR; Hashemi M
Acta Gastroenterol Belg; 2009; 72(3):301-5. PubMed ID: 19902862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
